Lief Fenno and a team from St. Jude Children’s Research Hospital traced connectivity between neurons to identify how the ...

Neuron, Cell Press’s prestigious neuroscience journal, is publishing a special issue on aging research on January 8, 2025.

Motor neuron disease usually refers to amyotrophic lateral sclerosis, but it can also refer to other kind of neurodegenerative disease that affect the motor neurons, such as progressive primary ...

This important study leverages the power of Drosophila genetics and sparsely-labeled neurons to propose a new model for neuronal injury signaling. The authors present convincing evidence to support ...

Some muscles are resistant to the loss of motor neurons seen in patients with spinal muscular atrophy, and new research has ...

Worldwide, age-related macular degeneration (AMD) is the leading cause of severe vision loss in people aged 50 or older. Neovascular AMD is an advanced form of the condition, also known as “exudative ...

for Neurizon’s lead drug candidate NUZ-001 – for the treatment of amyotrophic lateral sclerosis (ALS), also known as motor neurone disease. An OMPD provides a robust framework of benefits ...

Age-related macular degeneration (AMD) has three stages: early, intermediate, and late stage. Vision loss usually happens in the last stage of AMD. However, not everyone with AMD progresses through ...

You might develop blurry vision or other trouble seeing. This could be a sign of age-related macular degeneration (AMD). Wet AMD is the advanced form of the disease. It happens when new blood ...

Motor neuron diseases (MND), such as amyotrophic lateral sclerosis (ALS), are rare and debilitating conditions affecting the nervous system, leading to muscle weakness. Despite extensive research ...

NUZ-001 shows encouraging results in slowing disease progression and increasing life expectancy of patients with ALS Patients are now in their 27th month of continuous treatment with NUZ-001, with ...